Month: November 2024

  Photo credit: Melisa Slep by Rishita Nandagiri and Lucía Berro Pizzarossa Discussions about abortion tend to be dominated by considerations pertaining to medicine (e.g., “safety”) and law (e.g., “legality”). Medication abortion — misoprostol alone or in combination with mifepristone — has dramatically shifted these discussions. Brazilian women used misoprostol to self-manage their abortions in … Continue reading “Abortion debt: revolutionary acts and reclamations of care”

  Photo credit: Farrah Skeiky by Patty Skuster and Heidi Moseson Medication abortion did not begin with a clinical trial; it began at home as self-managed abortion, or abortion without supervision from a clinician. Decades before the 2000 U.S. Food and Drug Administration’s (FDA) approval of mifepristone for abortion, which is taken alongside misoprostol, feminists in … Continue reading “A full circle moment: legal risks to mifepristone and evidence for abortion with misoprostol alone”

by Elena Caruso While the exact definition of self-managed abortion remains blurred, it currently tends to refer to the end of a pregnancy through the autonomous administration of pills outside of a public health facility. The World Health Organization (WHO) recommends self-management for pregnancies under 12 weeks, using a combination of mifepristone and misoprostol (or … Continue reading “Does History Matter?”